Time-independent proportionality between red marrow and plasma activity concentration may be too simplistic. Individualized imaged-based dosimetry is probably required for the optimal therapeutic delivery of radiolabeled antibodies, which does not compromise red marrow and may allow, for some patients, a substantial increase in administered activity and thus tumor dose, based on a study in the April issue in the Journal of Nuclear Medicine.
Although the number of overall colorectal cancer cases has dropped in the U.S. in the last decade, one group, young adults, has seen an increase in the colorectal cancer rate. Every year since 1992, the number of people diagnosed with the disease before age 50 has increased by 2 percent, and cancer experts don’t yet understand why.
Rates of death in the U.S. from all cancers for men and women continued to decline between 2004 and 2008, according to the “Annual Report to the Nation on the Status of Cancer,” published online in Cancer on March 28.
There is little evidence to support the use of PET/CT imaging in the pre-operative staging of primary colorectal cancer, according to research published in the October edition of Health Technology Assessment.
Over the next decade, the population of cancer survivors over 65 years of age will increase by approximately 42 percent, according to a report published in the October issue of Cancer Epidemiology, Biomarkers & Prevention.
Infinitt North America, a developer of image and information management technologies for healthcare, has received FDA clearance for its fusion software, Xelis Fusion. The software is now available to the North American market.
PET imaging is showing a 7 percent average annual growth rate from 2008 to 2010, which is a decrease from the average annual rate of 10.4 percent from 2005 to 2008, according to IMV's research report, 2011 PET Market Summary Report.
A steady reduction in overall cancer death rates translates into the avoidance of about 898,000 deaths from cancer between 1990 and 2007, according to the latest statistics from the American Cancer Society (ACS).
|
|
|
|